Paper17530850
Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging.
Kim D and 4 others. J Am Chem Soc, 2007. Cited by 529 papers, by iCite.
Cite this record
ConductScience Library. Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. Papers, record 17530850. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17530850
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Contrast Media | Major topic |
| Gold | Major topic |
| Metal Nanoparticles | Major topic |
| Polymers | Major topic |
| Animals | |
| Carcinoma, Hepatocellular | |
| Male | |
| Rats | |
| Rats, Sprague-Dawley |
Source PubMed
Cited by187
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 529 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909384 | Atherosclerosis nanotheranostics: a perspective from macrophages. | Theranostics | 2026 | https://conductscience.org/library/papers/42909384 | PubMed |
| 42376707 | Contrast Agents for Enhanced Bioimaging: A Comprehensive Review. | Chembiochem | 2026 | https://conductscience.org/library/papers/42376707 | PubMed |
| 41940236 | Metallic nanoparticles: from biosynthesis to biomedical applications, current scenarios and prospects. | Nanoscale Adv | 2026 | https://conductscience.org/library/papers/41940236 | PubMed |
| 40661692 | Metallic Nanoparticles Applications in Neurological Disorders: A Review. | Int J Biomater | 2025 | https://conductscience.org/library/papers/40661692 | PubMed |
| 39989765 | Advancements in Micro/Nanorobots in Medicine: Design, Actuation, and Transformative Application. | ACS Omega | 2025 | https://conductscience.org/library/papers/39989765 | PubMed |
| 39046153 | Charged Gold Nanoparticles for Target Identification-Alignment and Automatic Segmentation of CT Image-Guided Adaptive Radiotherapy in Small Hepatocellular Carcinoma. | Nano Lett | 2024 | https://conductscience.org/library/papers/39046153 | PubMed |
| 38332327 | Advances in nanotechnology-based targeted-contrast agents for computed tomography and magnetic resonance. | Sci Prog | 2024 | https://conductscience.org/library/papers/38332327 | PubMed |
| 38164503 | Gold Polymer Nanomaterials: A Promising Approach for Enhanced Biomolecular Imaging. | Nanotheranostics | 2024 | https://conductscience.org/library/papers/38164503 | PubMed |
| 38089921 | Progress and prospect of nanotechnology for cardiac fibrosis treatment. | Interdiscip Med | 2023 | https://conductscience.org/library/papers/38089921 | PubMed |
| 37895934 | Heavy Metal-Based Nanoparticles as High-Performance X-ray Computed Tomography Contrast Agents. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37895934 | PubMed |
| 37876497 | Functional Diversity in Radiolabeled Nanoceramics and Related Biomaterials for the Multimodal Imaging of Tumors. | ACS Bio Med Chem Au | 2023 | https://conductscience.org/library/papers/37876497 | PubMed |
| 37842655 | Applications and safety of gold nanoparticles as therapeutic devices in clinical trials. | J Pharm Anal | 2023 | https://conductscience.org/library/papers/37842655 | PubMed |
| 36903686 | Facile Synthesis and X-ray Attenuation Properties of Ultrasmall Platinum Nanoparticles Grafted with Three Types of Hydrophilic Polymers. | Nanomaterials (Basel) | 2023 | https://conductscience.org/library/papers/36903686 | PubMed |
| 36866254 | Green room temperature synthesis of silver-gold alloy nanoparticles. | Nanoscale Adv | 2023 | https://conductscience.org/library/papers/36866254 | PubMed |
| 36865684 | Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts. | Cancer Nanotechnol | 2023 | https://conductscience.org/library/papers/36865684 | PubMed |
| 36741760 | Aptamer-conjugated gold nanoparticles and their diagnostic and therapeutic roles in cancer. | Front Bioeng Biotechnol | 2023 | https://conductscience.org/library/papers/36741760 | PubMed |
| 36687113 | Chemically Functionalized Gold Nanosphere-Blended Nematic Liquid Crystals for Photonic Applications. | ACS Omega | 2023 | https://conductscience.org/library/papers/36687113 | PubMed |
| 36662059 | Polyethyleneimine-Based Drug Delivery Systems for Cancer Theranostics. | J Funct Biomater | 2022 | https://conductscience.org/library/papers/36662059 | PubMed |
| 36318182 | Zonal Intratumoral Delivery of Nanoparticles Guided by Surface Functionalization. | Langmuir | 2022 | https://conductscience.org/library/papers/36318182 | PubMed |
| 36313319 | Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36313319 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17530850
GET https://conductscience.org/api/papers/v1/17530850/cited_by?page=2